Chargement en cours...
Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response
Amyloid light chain (AL) amyloidosis is a systemic disease characterised by the aggregation of misfolded immunoglobulin light chain (LC), predominantly in the heart and kidneys, causing organ failure. If untreated, the median survival of patients with cardiac AL amyloidosis is 6 months from the onse...
Enregistré dans:
| Publié dans: | Heart |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Publishing Group
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5566095/ https://ncbi.nlm.nih.gov/pubmed/28456755 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/heartjnl-2016-310704 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|